Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
复制标题
DOI：
10.1016/s0140-6736(21)02507-1
复制
发表时间：
2021-12-11
期刊：
影响因子：
--
通讯作者：
Hotez PJ
中科院分区：
文献类型：
--
作者：
Omer SB;Benjamin RM;Brewer NT;Buttenheim AM;Callaghan T;Caplan A;Carpiano RM;Clinton C;DiResta R;Elharake JA;Flowers LC;Galvani AP;Lakshmanan R;Maldonado YA;McFadden SM;Mello MM;Opel DJ;Reiss DR;Salmon DA;Schwartz JL;Sharfstein JM;Hotez PJ
自2020年1月在美国发现第一例COVID-19病例以来，该国已有超过4600万人检测出SARS-CoV-2感染阳性。几种COVID-19疫苗已获得美国食品和药物管理局的紧急使用授权，其中辉瑞- biontech疫苗于2021年8月23日获得全面批准。当与口罩、保持身体距离和通风配合使用时，COVID-19疫苗是可持续控制大流行的最佳干预措施。然而，调查一直发现，相当多的少数美国居民不打算接种COVID-19疫苗。不充分接种COVID-19疫苗的最严重后果是持续的社区传播（包括delta [B.1.617.2]变体，其激增始于2021年7月）。COVID-19疫苗的低接种率加剧了该病毒的直接影响，将使大流行对家庭和社区，特别是低收入和少数民族群体的社会和经济影响延长到2022年，甚至更长。COVID-19疫苗接种运动的规模和挑战是前所未有的。因此，通过一系列建议，我们提出了一项协调一致的、以证据为基础的教育、沟通和行为干预战略，这可能会提高美国COVID-19疫苗规划的成功率。
Since the first case of COVID-19 was identified in the USA in January, 2020, over 46 million people in the country have tested positive for SARS-CoV-2 infection. Several COVID-19 vaccines have received emergency use authorisations from the US Food and Drug Administration, with the Pfizer–BioNTech vaccine receiving full approval on Aug 23, 2021. When paired with masking, physical distancing, and ventilation, COVID-19 vaccines are the best intervention to sustainably control the pandemic. However, surveys have consistently found that a sizeable minority of US residents do not plan to get a COVID-19 vaccine. The most severe consequence of an inadequate uptake of COVID-19 vaccines has been sustained community transmission (including of the delta [B.1.617.2] variant, a surge of which began in July, 2021). Exacerbating the direct impact of the virus, a low uptake of COVID-19 vaccines will prolong the social and economic repercussions of the pandemic on families and communities, especially low-income and minority ethnic groups, into 2022, or even longer. The scale and challenges of the COVID-19 vaccination campaign are unprecedented. Therefore, through a series of recommendations, we present a coordinated, evidence-based education, communication, and behavioural intervention strategy that is likely to improve the success of COVID-19 vaccine programmes across the USA.